Clinical Trial Update: Toll-like Receptor 9 Agonist Treatment in Chronic HIV-1 Infection [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating a Toll-like receptor 9 agonist for chronic HIV infection has completed. The snippet does not include trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TLR9 agonist (Toll-like receptor 9 agonist)

Snippet

Sponsor: University of Aarhus | Conditions: HIV | Phase 1, Phase 2 | Status: COMPLETED